The Asian Pacific Association for the Study of the Liver [APASL]

Hepatology International Online Free Subscription is available for all APASL members through the login page!

APASL-ONCOLOGY 2026 TOKYO

Abstract submission deadline has been extended until

January 20, 2026 ! 

Dear Colleagues,

A Happy New Year!

I hope this message finds you well, and I would like to extend my sincere best wishes to you for a successful and fulfilling year ahead.

First of all, I would like to express my deepest appreciation for your continued dedication to APASL and its scientific activities. It is grateful to announce you the APASL-ONCOLOGY 2026 TOKYO will be held on April 2–3, 2026, at the University of Tokyo. And now we are calling for free papers.

While we have received a strong number of abstracts to date, further high-quality submissions from across the Asia-Pacific region will be essential to ensure both scientific excellence and regional diversity of this meeting.

To allow additional time for colleagues to prepare their submissions, the abstract submission deadline has been extended until January 20, 2026. We would be most grateful if you could submit abstracts, and encourage among your colleagues, institutions, and professional networks.

Abstract Submission Site URL https://www.apasl-oncology2026tokyo.org/abs.html

In particular, we would like to highlight:

  • Presidential Awards, recognizing outstanding scientific contributions
  • Video Sessions and Video Awards, focusing on interventional, endoscopic, surgical, and educational procedures, which we strongly encourage, especially from emerging leaders in the field

Your entry and participation would be invaluable for the success of this APASL oncology meeting.

Thank you very much for your continued commitment to APASL. We look forward to welcoming you to Tokyo.

With my warmest regards and best wishes for the New Year,

Shuntaro Obi, MD, PhD
Congress President
APASL-ONCOLOGY 2026 TOKYO
Tokyo, Japan

Contact:

APASL Oncology 2026 Tokyo Congress Secretariat

Tel: +81-3-6380-0102  Fax: +81-3-6380-0103

Email: info@apasl-oncology2026tokyo.org

https://www.apasl-oncology2026tokyo.org